東軟醫療宣佈捐贈價值2700萬元高端CT設備及軟件 支援武漢抗擊新冠病毒肺炎
萬眾一心,眾志成城!疫情面前共擔當!——全國上下正以非常之役迎戰非常之疫,東軟醫療也在第一時間組建了以CEO為核心的應急指揮中心,全面調動研發、生產、物流、服務、培訓等資源,支援抗疫前線。
剛剛,東軟醫療繼向湖北、河南、江西、山東、遼寧、吉林、四川等抗疫前線閃電發出CT、車載CT、移動DR數十台醫療設備後,分別向武漢市雷神山醫院捐贈NeuViz 128 CT一台及東軟醫療智能醫學影像雲平台、遠程高級後處理軟件各一套,向華中科技大學同濟醫學院附屬同濟醫院捐贈NeuViz Prime CT一台及東軟醫療智能醫學影像雲平台、遠程高級後處理軟件各一套,總價值共計2700萬元。支援武漢共克時艱,共渡難關!


東軟醫療工作人員加班加點 順利完成捐贈設備發機任務

央視新聞直播東軟醫療抗疫行動
目前,由於新型冠狀病毒肺炎的肺部CT徵象已明確,CT成為病情診斷的重要手段。武漢市中心醫院放射科在此前發佈的給全國放射技術人員的建議中,也明確提到:“19-nCoV肺炎早期影像診斷基本靠CT,而且是要薄層的多層螺旋CT。”
在與武漢當地政府、武漢市雷神山醫院、華中科技大學同濟醫學院附屬同濟醫院及湖北省紅十字會充分溝通後,東軟醫療啟動捐贈行動。

東軟醫療總裁兼首席運營官江根苗接受《央視新聞》採訪
據瞭解,此次捐贈的NeuViz 128 CT、NeuViz Prime CT設備搭載了東軟醫療智能醫學影像雲平台、遠程高級後處理軟件,通過智能醫學影像雲平台(NeuMiva),可實現醫學影像的傳輸及管理、電子膠片生成和瀏覽、移動辦公、互動社區及遠程診斷一體化。此外,平台上加載了多種智能化軟件,包括40餘種圖像增強和後處理工具,以及骨密度測量、乳腺篩查、肺結節篩查、卒中定量診斷等多種輔助診斷功能。
這意味着,武漢市雷神山醫院、華中科技大學同濟醫學院附屬同濟醫院在使用東軟醫療所捐贈設備時,不僅可藉助智能軟件幫助醫生提升診斷效率,而且實現了各醫院間的互通互聯,可方便及時地傳遞疫情動態。必要時,還可通過東軟醫療智能醫學影像雲平台溝通有效的診療方法,讓分佈各處的專家聯合會診。
此次捐贈行動只是東軟醫療“全面抗疫”的一個里程碑,公司還將繼續幫助全國的醫療機構與醫務工作者,不僅快速的完成設備配貨與安裝,還將主動的遠程運行巡檢及24小時不間斷的技術支持。在疫情結束之前,東軟醫療的馳援不會停止。“為醫療機構創造價值,惠及人類健康”,這是東軟醫療的使命,我們將與戰鬥在一線的醫護人員同擔當、共守護,一起打贏這場全中國的健康保衞戰!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.